<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="1991-02-01" modified="2017-05-10" version="206">
<accession>P19525</accession>
<accession>A8K3P0</accession>
<accession>D6W584</accession>
<accession>E9PC80</accession>
<accession>Q52M43</accession>
<accession>Q7Z6F6</accession>
<accession>Q9UIR4</accession>
<name>E2AK2_HUMAN</name>
<protein>
<recommendedName>
<fullName>Interferon-induced, double-stranded RNA-activated protein kinase</fullName>
<ecNumber>2.7.11.1</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Eukaryotic translation initiation factor 2-alpha kinase 2</fullName>
<shortName>eIF-2A protein kinase 2</shortName>
</alternativeName>
<alternativeName>
<fullName>Interferon-inducible RNA-dependent protein kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>P1/eIF-2A protein kinase</fullName>
</alternativeName>
<alternativeName>
<fullName>Protein kinase RNA-activated</fullName>
<shortName>PKR</shortName>
<shortName evidence="61">Protein kinase R</shortName>
</alternativeName>
<alternativeName>
<fullName>Tyrosine-protein kinase EIF2AK2</fullName>
<ecNumber>2.7.10.2</ecNumber>
</alternativeName>
<alternativeName>
<fullName>p68 kinase</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">EIF2AK2</name>
<name type="synonym">PKR</name>
<name type="synonym">PRKR</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1990" name="Cell" volume="62" first="379" last="390">
<title>Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon.</title>
<authorList>
<person name="Meurs E."/>
<person name="Chong K."/>
<person name="Galabru J."/>
<person name="Thomas N.S.B."/>
<person name="Kerr I.M."/>
<person name="Williams B.R.G."/>
<person name="Hovanessian A.G."/>
</authorList>
<dbReference type="PubMed" id="1695551"/>
<dbReference type="DOI" id="10.1016/0092-8674(90)90374-N"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>PROTEIN SEQUENCE OF 101-118 AND 309-325</scope>
<scope>INDUCTION</scope>
</reference>
<reference key="2">
<citation type="submission" date="1990-08" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Meurs E."/>
</authorList>
</citation>
<scope>SEQUENCE REVISION</scope>
</reference>
<reference key="3">
<citation type="journal article" date="1992" name="Virology" volume="188" first="33" last="46">
<title>Mechanism of interferon action: cDNA structure, expression, and regulation of the interferon-induced, RNA-dependent P1/eIF-2 alpha protein kinase from human cells.</title>
<authorList>
<person name="Thomis D.C."/>
<person name="Doohan J.P."/>
<person name="Samuel C.E."/>
</authorList>
<dbReference type="PubMed" id="1373553"/>
<dbReference type="DOI" id="10.1016/0042-6822(92)90732-5"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="1996" name="Gene" volume="178" first="191" last="193">
<title>Mechanism of interferon action sequence of the human interferon-inducible RNA-dependent protein kinase (PKR) deduced from genomic clones.</title>
<authorList>
<person name="Kuhen K.L."/>
<person name="Shen X."/>
<person name="Samuel C.E."/>
</authorList>
<dbReference type="PubMed" id="8921913"/>
<dbReference type="DOI" id="10.1016/0378-1119(96)00314-9"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1)</scope>
</reference>
<reference key="5">
<citation type="journal article" date="1996" name="Genomics" volume="36" first="197" last="201">
<title>Structural organization of the human gene (PKR) encoding an interferon-inducible RNA-dependent protein kinase (PKR) and differences from its mouse homolog.</title>
<authorList>
<person name="Kuhen K.L."/>
<person name="Shen X."/>
<person name="Carlisle E.R."/>
<person name="Richardson A.L."/>
<person name="Weier H.-U.G."/>
<person name="Tanaka H."/>
<person name="Samuel C.E."/>
</authorList>
<dbReference type="PubMed" id="8812437"/>
<dbReference type="DOI" id="10.1006/geno.1996.0446"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<source>
<tissue>Placenta</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="1998" name="J. Interferon Cytokine Res." volume="18" first="609" last="616">
<title>Genomic features of human PKR: alternative splicing and a polymorphic CGG repeat in the 5'-untranslated region.</title>
<authorList>
<person name="Xu Z."/>
<person name="Williams B.R."/>
</authorList>
<dbReference type="PubMed" id="9726442"/>
<dbReference type="DOI" id="10.1089/jir.1998.18.609"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="7">
<citation type="submission" date="2003-05" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Li H."/>
<person name="Huang F."/>
<person name="Shen C."/>
<person name="Zhou G."/>
<person name="Zheng G."/>
<person name="Ke R."/>
<person name="Lin L."/>
<person name="Yang S."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Embryo</tissue>
</source>
</reference>
<reference key="9">
<citation type="submission" date="2003-01" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NIEHS SNPs program"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="Nature" volume="434" first="724" last="731">
<title>Generation and annotation of the DNA sequences of human chromosomes 2 and 4.</title>
<authorList>
<person name="Hillier L.W."/>
<person name="Graves T.A."/>
<person name="Fulton R.S."/>
<person name="Fulton L.A."/>
<person name="Pepin K.H."/>
<person name="Minx P."/>
<person name="Wagner-McPherson C."/>
<person name="Layman D."/>
<person name="Wylie K."/>
<person name="Sekhon M."/>
<person name="Becker M.C."/>
<person name="Fewell G.A."/>
<person name="Delehaunty K.D."/>
<person name="Miner T.L."/>
<person name="Nash W.E."/>
<person name="Kremitzki C."/>
<person name="Oddy L."/>
<person name="Du H."/>
<person name="Sun H."/>
<person name="Bradshaw-Cordum H."/>
<person name="Ali J."/>
<person name="Carter J."/>
<person name="Cordes M."/>
<person name="Harris A."/>
<person name="Isak A."/>
<person name="van Brunt A."/>
<person name="Nguyen C."/>
<person name="Du F."/>
<person name="Courtney L."/>
<person name="Kalicki J."/>
<person name="Ozersky P."/>
<person name="Abbott S."/>
<person name="Armstrong J."/>
<person name="Belter E.A."/>
<person name="Caruso L."/>
<person name="Cedroni M."/>
<person name="Cotton M."/>
<person name="Davidson T."/>
<person name="Desai A."/>
<person name="Elliott G."/>
<person name="Erb T."/>
<person name="Fronick C."/>
<person name="Gaige T."/>
<person name="Haakenson W."/>
<person name="Haglund K."/>
<person name="Holmes A."/>
<person name="Harkins R."/>
<person name="Kim K."/>
<person name="Kruchowski S.S."/>
<person name="Strong C.M."/>
<person name="Grewal N."/>
<person name="Goyea E."/>
<person name="Hou S."/>
<person name="Levy A."/>
<person name="Martinka S."/>
<person name="Mead K."/>
<person name="McLellan M.D."/>
<person name="Meyer R."/>
<person name="Randall-Maher J."/>
<person name="Tomlinson C."/>
<person name="Dauphin-Kohlberg S."/>
<person name="Kozlowicz-Reilly A."/>
<person name="Shah N."/>
<person name="Swearengen-Shahid S."/>
<person name="Snider J."/>
<person name="Strong J.T."/>
<person name="Thompson J."/>
<person name="Yoakum M."/>
<person name="Leonard S."/>
<person name="Pearman C."/>
<person name="Trani L."/>
<person name="Radionenko M."/>
<person name="Waligorski J.E."/>
<person name="Wang C."/>
<person name="Rock S.M."/>
<person name="Tin-Wollam A.-M."/>
<person name="Maupin R."/>
<person name="Latreille P."/>
<person name="Wendl M.C."/>
<person name="Yang S.-P."/>
<person name="Pohl C."/>
<person name="Wallis J.W."/>
<person name="Spieth J."/>
<person name="Bieri T.A."/>
<person name="Berkowicz N."/>
<person name="Nelson J.O."/>
<person name="Osborne J."/>
<person name="Ding L."/>
<person name="Meyer R."/>
<person name="Sabo A."/>
<person name="Shotland Y."/>
<person name="Sinha P."/>
<person name="Wohldmann P.E."/>
<person name="Cook L.L."/>
<person name="Hickenbotham M.T."/>
<person name="Eldred J."/>
<person name="Williams D."/>
<person name="Jones T.A."/>
<person name="She X."/>
<person name="Ciccarelli F.D."/>
<person name="Izaurralde E."/>
<person name="Taylor J."/>
<person name="Schmutz J."/>
<person name="Myers R.M."/>
<person name="Cox D.R."/>
<person name="Huang X."/>
<person name="McPherson J.D."/>
<person name="Mardis E.R."/>
<person name="Clifton S.W."/>
<person name="Warren W.C."/>
<person name="Chinwalla A.T."/>
<person name="Eddy S.R."/>
<person name="Marra M.A."/>
<person name="Ovcharenko I."/>
<person name="Furey T.S."/>
<person name="Miller W."/>
<person name="Eichler E.E."/>
<person name="Bork P."/>
<person name="Suyama M."/>
<person name="Torrents D."/>
<person name="Waterston R.H."/>
<person name="Wilson R.K."/>
</authorList>
<dbReference type="PubMed" id="15815621"/>
<dbReference type="DOI" id="10.1038/nature03466"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="11">
<citation type="submission" date="2005-09" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="13">
<citation type="submission" date="2009-06" db="UniProtKB">
<authorList>
<person name="Bienvenut W.V."/>
<person name="Gao M."/>
<person name="Leug H."/>
</authorList>
</citation>
<scope>PROTEIN SEQUENCE OF 2-18; 27-40; 70-77; 414-426 AND 430-440</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE</scope>
<scope>ACETYLATION AT ALA-2</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<source>
<tissue>Prostatic carcinoma</tissue>
</source>
</reference>
<reference key="14">
<citation type="journal article" date="1996" name="J. Biol. Chem." volume="271" first="1702" last="1707">
<title>The P58 cellular inhibitor complexes with the interferon-induced, double-stranded RNA-dependent protein kinase, PKR, to regulate its autophosphorylation and activity.</title>
<authorList>
<person name="Polyak S.J."/>
<person name="Tang N."/>
<person name="Wambach M."/>
<person name="Barber G.N."/>
<person name="Katze M.G."/>
</authorList>
<dbReference type="PubMed" id="8576172"/>
<dbReference type="DOI" id="10.1074/jbc.271.3.1702"/>
</citation>
<scope>INTERACTION WITH DNAJC3</scope>
</reference>
<reference key="15">
<citation type="journal article" date="1997" name="J. Biol. Chem." volume="272" first="8388" last="8395">
<title>The Tat protein of human immunodeficiency virus type 1 is a substrate and inhibitor of the interferon-induced, virally activated protein kinase, PKR.</title>
<authorList>
<person name="Brand S.R."/>
<person name="Kobayashi R."/>
<person name="Mathews M.B."/>
</authorList>
<dbReference type="PubMed" id="9079663"/>
<dbReference type="DOI" id="10.1074/jbc.272.13.8388"/>
</citation>
<scope>INTERACTION WITH HIV-1 TAT</scope>
</reference>
<reference key="16">
<citation type="journal article" date="1997" name="Virology" volume="230" first="217" last="227">
<title>Evidence that hepatitis C virus resistance to interferon is mediated through repression of the PKR protein kinase by the nonstructural 5A protein.</title>
<authorList>
<person name="Gale M.J. Jr."/>
<person name="Korth M.J."/>
<person name="Tang N.M."/>
<person name="Tan S.-L."/>
<person name="Hopkins D.A."/>
<person name="Dever T.E."/>
<person name="Polyak S.J."/>
<person name="Gretch D.R."/>
<person name="Katze M.G."/>
</authorList>
<dbReference type="PubMed" id="9143277"/>
<dbReference type="DOI" id="10.1006/viro.1997.8493"/>
</citation>
<scope>INTERACTION WITH HCV NS5A</scope>
</reference>
<reference key="17">
<citation type="journal article" date="1998" name="J. Interferon Cytokine Res." volume="18" first="757" last="766">
<title>Biochemical and genetic evidence for complex formation between the influenza A virus NS1 protein and the interferon-induced PKR protein kinase.</title>
<authorList>
<person name="Tan S.L."/>
<person name="Katze M.G."/>
</authorList>
<dbReference type="PubMed" id="9781815"/>
<dbReference type="DOI" id="10.1089/jir.1998.18.757"/>
</citation>
<scope>INTERACTION WITH INFLUENZA A NS1 PROTEIN</scope>
</reference>
<reference key="18">
<citation type="journal article" date="1999" name="Science" volume="285" first="107" last="110">
<title>Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein.</title>
<authorList>
<person name="Taylor D.R."/>
<person name="Shi S.T."/>
<person name="Romano P.R."/>
<person name="Barber G.N."/>
<person name="Lai M.M.C."/>
</authorList>
<dbReference type="PubMed" id="10390359"/>
<dbReference type="DOI" id="10.1126/science.285.5424.107"/>
</citation>
<scope>INTERACTION WITH HCV E2 ENVELOPE PROTEIN</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2000" name="Mol. Cell. Biol." volume="20" first="4532" last="4542">
<title>PKR stimulates NF-kappaB irrespective of its kinase function by interacting with the IkappaB kinase complex.</title>
<authorList>
<person name="Bonnet M.C."/>
<person name="Weil R."/>
<person name="Dam E."/>
<person name="Hovanessian A.G."/>
<person name="Meurs E.F."/>
</authorList>
<dbReference type="PubMed" id="10848580"/>
<dbReference type="DOI" id="10.1128/MCB.20.13.4532-4542.2000"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH IKBKB</scope>
</reference>
<reference key="20">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="33899" last="33905">
<title>Two dimerization domains in the trans-activation response RNA-binding protein (TRBP) individually reverse the protein kinase R inhibition of HIV-1 long terminal repeat expression.</title>
<authorList>
<person name="Daher A."/>
<person name="Longuet M."/>
<person name="Dorin D."/>
<person name="Bois F."/>
<person name="Segeral E."/>
<person name="Bannwarth S."/>
<person name="Battisti P.-L."/>
<person name="Purcell D.F."/>
<person name="Benarous R."/>
<person name="Vaquero C."/>
<person name="Meurs E.F."/>
<person name="Gatignol A."/>
</authorList>
<dbReference type="PubMed" id="11438532"/>
<dbReference type="DOI" id="10.1074/jbc.M103584200"/>
</citation>
<scope>INTERACTION WITH TARBP2</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2001" name="J. Virol." volume="75" first="1265" last="1273">
<title>Hepatitis C virus envelope protein E2 does not inhibit PKR by simple competition with autophosphorylation sites in the RNA-binding domain.</title>
<authorList>
<person name="Taylor D.R."/>
<person name="Tian B."/>
<person name="Romano P.R."/>
<person name="Hinnebusch A.G."/>
<person name="Lai M.M.C."/>
<person name="Mathews M.B."/>
</authorList>
<dbReference type="PubMed" id="11152499"/>
<dbReference type="DOI" id="10.1128/JVI.75.3.1265-1273.2001"/>
</citation>
<scope>PHOSPHORYLATION AT SER-83; THR-88; THR-89; THR-90; SER-242; THR-255 AND THR-258</scope>
<scope>MUTAGENESIS OF SER-83; THR-88; THR-89; THR-90; SER-242; THR-255; THR-258 AND LYS-296</scope>
<scope>INHIBITION BY HCV E2 ENVELOPE PROTEIN</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="24946" last="24958">
<title>Binding of double-stranded RNA to protein kinase PKR is required for dimerization and promotes critical autophosphorylation events in the activation loop.</title>
<authorList>
<person name="Zhang F."/>
<person name="Romano P.R."/>
<person name="Nagamura-Inoue T."/>
<person name="Tian B."/>
<person name="Dever T.E."/>
<person name="Mathews M.B."/>
<person name="Ozato K."/>
<person name="Hinnebusch A.G."/>
</authorList>
<dbReference type="PubMed" id="11337501"/>
<dbReference type="DOI" id="10.1074/jbc.M102108200"/>
</citation>
<scope>MUTAGENESIS</scope>
<scope>PHOSPHORYLATION AT THR-446 AND THR-451</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2001" name="J. Virol." volume="75" first="2345" last="2352">
<title>Latently expressed human herpesvirus 8-encoded interferon regulatory factor 2 inhibits double-stranded RNA-activated protein kinase.</title>
<authorList>
<person name="Burysek L."/>
<person name="Pitha P.M."/>
</authorList>
<dbReference type="PubMed" id="11160738"/>
<dbReference type="DOI" id="10.1128/JVI.75.5.2345-2352.2001"/>
</citation>
<scope>INTERACTION WITH HHV-8 PROTEIN VIRF2</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2002" name="J. Virol." volume="76" first="2029" last="2035">
<title>The herpes simplex virus type 1 U(S)11 protein interacts with protein kinase R in infected cells and requires a 30-amino-acid sequence adjacent to a kinase substrate domain.</title>
<authorList>
<person name="Cassady K.A."/>
<person name="Gross M."/>
</authorList>
<dbReference type="PubMed" id="11836380"/>
<dbReference type="DOI" id="10.1128/jvi.76.5.2029-2035.2002"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH HHV-1 US11</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="41709" last="41717">
<title>Nucleophosmin interacts with and inhibits the catalytic function of eukaryotic initiation factor 2 kinase PKR.</title>
<authorList>
<person name="Pang Q."/>
<person name="Christianson T.A."/>
<person name="Koretsky T."/>
<person name="Carlson H."/>
<person name="David L."/>
<person name="Keeble W."/>
<person name="Faulkner G.R."/>
<person name="Speckhart A."/>
<person name="Bagby G.C."/>
</authorList>
<dbReference type="PubMed" id="12882984"/>
<dbReference type="DOI" id="10.1074/jbc.M301392200"/>
</citation>
<scope>INTERACTION WITH NPM1</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="37670" last="37676">
<title>Protein kinase R (PKR) interacts with and activates mitogen-activated protein kinase kinase 6 (MKK6) in response to double-stranded RNA stimulation.</title>
<authorList>
<person name="Silva A.M."/>
<person name="Whitmore M."/>
<person name="Xu Z."/>
<person name="Jiang Z."/>
<person name="Li X."/>
<person name="Williams B.R."/>
</authorList>
<dbReference type="PubMed" id="15229216"/>
<dbReference type="DOI" id="10.1074/jbc.M406554200"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH MAP2K6</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2004" name="J. Biol. Chem." volume="279" first="43910" last="43919">
<title>The Fanconi anemia proteins functionally interact with the protein kinase regulated by RNA (PKR).</title>
<authorList>
<person name="Zhang X."/>
<person name="Li J."/>
<person name="Sejas D.P."/>
<person name="Rathbun K.R."/>
<person name="Bagby G.C."/>
<person name="Pang Q."/>
</authorList>
<dbReference type="PubMed" id="15299030"/>
<dbReference type="DOI" id="10.1074/jbc.M403884200"/>
</citation>
<scope>IDENTIFICATION IN A COMPLEX WITH FANCA; FANCC; FANCG AND HSP70</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2004" name="Mol. Cell. Biol." volume="24" first="4502" last="4512">
<title>TRAF family proteins link PKR with NF-kappa B activation.</title>
<authorList>
<person name="Gil J."/>
<person name="Garcia M.A."/>
<person name="Gomez-Puertas P."/>
<person name="Guerra S."/>
<person name="Rullas J."/>
<person name="Nakano H."/>
<person name="Alcami J."/>
<person name="Esteban M."/>
</authorList>
<dbReference type="PubMed" id="15121867"/>
<dbReference type="DOI" id="10.1128/MCB.24.10.4502-4512.2004"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH TRAF2; TRAF5 AND TRAF6</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2004" name="Virology" volume="324" first="419" last="429">
<title>Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L.</title>
<authorList>
<person name="Langland J.O."/>
<person name="Jacobs B.L."/>
</authorList>
<dbReference type="PubMed" id="15207627"/>
<dbReference type="DOI" id="10.1016/j.virol.2004.03.012"/>
</citation>
<scope>INHIBITION BY VACCINIA VIRUS PROTEIN E3</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2006" name="Microbiol. Mol. Biol. Rev." volume="70" first="1032" last="1060">
<title>Impact of protein kinase PKR in cell biology: from antiviral to antiproliferative action.</title>
<authorList>
<person name="Garcia M.A."/>
<person name="Gil J."/>
<person name="Ventoso I."/>
<person name="Guerra S."/>
<person name="Domingo E."/>
<person name="Rivas C."/>
<person name="Esteban M."/>
</authorList>
<dbReference type="PubMed" id="17158706"/>
<dbReference type="DOI" id="10.1128/MMBR.00027-06"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2006" name="Proc. Natl. Acad. Sci. U.S.A." volume="103" first="63" last="68">
<title>Tyrosine phosphorylation acts as a molecular switch to full-scale activation of the eIF2alpha RNA-dependent protein kinase.</title>
<authorList>
<person name="Su Q."/>
<person name="Wang S."/>
<person name="Baltzis D."/>
<person name="Qu L.K."/>
<person name="Wong A.H."/>
<person name="Koromilas A.E."/>
</authorList>
<dbReference type="PubMed" id="16373505"/>
<dbReference type="DOI" id="10.1073/pnas.0508207103"/>
</citation>
<scope>PHOSPHORYLATION AT TYR-101; TYR-162 AND TYR-293</scope>
</reference>
<reference key="32">
<citation type="journal article" date="2007" name="J. Virol." volume="81" first="917" last="923">
<title>Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection.</title>
<authorList>
<person name="Nie Y."/>
<person name="Hammond G.L."/>
<person name="Yang J.H."/>
</authorList>
<dbReference type="PubMed" id="17079286"/>
<dbReference type="DOI" id="10.1128/JVI.01527-06"/>
</citation>
<scope>INTERACTION WITH ADAR</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2007" name="Trends Biochem. Sci." volume="32" first="57" last="62">
<title>Activation of PKR: an open and shut case?</title>
<authorList>
<person name="Cole J.L."/>
</authorList>
<dbReference type="PubMed" id="17196820"/>
<dbReference type="DOI" id="10.1016/j.tibs.2006.12.003"/>
</citation>
<scope>REVIEW ON ENZYME REGULATION</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="377" first="231" last="235">
<title>Nck-1 interacts with PKR and modulates its activation by dsRNA.</title>
<authorList>
<person name="Cardin E."/>
<person name="Larose L."/>
</authorList>
<dbReference type="PubMed" id="18835251"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.09.112"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NCK1</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="35">
<citation type="journal article" date="2008" name="Nucleic Acids Res." volume="36" first="998" last="1008">
<title>Interaction of human tRNA-dihydrouridine synthase-2 with interferon-induced protein kinase PKR.</title>
<authorList>
<person name="Mittelstadt M."/>
<person name="Frump A."/>
<person name="Khuu T."/>
<person name="Fowlkes V."/>
<person name="Handy I."/>
<person name="Patel C.V."/>
<person name="Patel R.C."/>
</authorList>
<dbReference type="PubMed" id="18096616"/>
<dbReference type="DOI" id="10.1093/nar/gkm1129"/>
</citation>
<scope>INTERACTION WITH DUS2L</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83 AND SER-456</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="37">
<citation type="journal article" date="2009" name="J. Cell. Physiol." volume="221" first="232" last="241">
<title>PKR activity is required for acute leukemic cell maintenance and growth: a role for PKR-mediated phosphatase activity to regulate GSK-3 phosphorylation.</title>
<authorList>
<person name="Blalock W.L."/>
<person name="Grimaldi C."/>
<person name="Fala F."/>
<person name="Follo M."/>
<person name="Horn S."/>
<person name="Basecke J."/>
<person name="Martinelli G."/>
<person name="Cocco L."/>
<person name="Martelli A.M."/>
</authorList>
<dbReference type="PubMed" id="19507191"/>
<dbReference type="DOI" id="10.1002/jcp.21848"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2009" name="PLoS Pathog." volume="5" first="E1000311" last="E1000311">
<title>An antiviral response directed by PKR phosphorylation of the RNA helicase A.</title>
<authorList>
<person name="Sadler A.J."/>
<person name="Latchoumanin O."/>
<person name="Hawkes D."/>
<person name="Mak J."/>
<person name="Williams B.R."/>
</authorList>
<dbReference type="PubMed" id="19229320"/>
<dbReference type="DOI" id="10.1371/journal.ppat.1000311"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH DHX9</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="40">
<citation type="journal article" date="2009" name="Virus Res." volume="142" first="51" last="56">
<title>PKR protein kinase is activated by hepatitis C virus and inhibits viral replication through translational control.</title>
<authorList>
<person name="Kang J.I."/>
<person name="Kwon S.N."/>
<person name="Park S.H."/>
<person name="Kim Y.K."/>
<person name="Choi S.Y."/>
<person name="Kim J.P."/>
<person name="Ahn B.Y."/>
</authorList>
<dbReference type="PubMed" id="19189853"/>
<dbReference type="DOI" id="10.1016/j.virusres.2009.01.007"/>
</citation>
<scope>FUNCTION IN HCV RESTRICTION</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2010" name="Cytokine" volume="50" first="210" last="219">
<title>A role for protein kinase PKR in the mediation of Epstein-Barr virus latent membrane protein-1-induced IL-6 and IL-10 expression.</title>
<authorList>
<person name="Lin S.S."/>
<person name="Lee D.C."/>
<person name="Law A.H."/>
<person name="Fang J.W."/>
<person name="Chua D.T."/>
<person name="Lau A.S."/>
</authorList>
<dbReference type="PubMed" id="20171114"/>
<dbReference type="DOI" id="10.1016/j.cyto.2010.01.008"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2010" name="EMBO Rep." volume="11" first="393" last="399">
<title>New Cdc2 Tyr 4 phosphorylation by dsRNA-activated protein kinase triggers Cdc2 polyubiquitination and G2 arrest under genotoxic stresses.</title>
<authorList>
<person name="Yoon C.-H."/>
<person name="Miah M.A."/>
<person name="Kim K.P."/>
<person name="Bae Y.-S."/>
</authorList>
<dbReference type="PubMed" id="20395957"/>
<dbReference type="DOI" id="10.1038/embor.2010.45"/>
</citation>
<scope>FUNCTION AS CDK1 KINASE UPON DNA DAMAGE</scope>
<scope>FUNCTION AS TYROSINE-PROTEIN KINASE</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2010" name="Genes Dev." volume="24" first="2640" last="2653">
<title>Phosphorylation of the NFAR proteins by the dsRNA-dependent protein kinase PKR constitutes a novel mechanism of translational regulation and cellular defense.</title>
<authorList>
<person name="Harashima A."/>
<person name="Guettouche T."/>
<person name="Barber G.N."/>
</authorList>
<dbReference type="PubMed" id="21123651"/>
<dbReference type="DOI" id="10.1101/gad.1965010"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2010" name="Liver Int." volume="30" first="311" last="318">
<title>Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatment.</title>
<authorList>
<person name="Chang J.H."/>
<person name="Kato N."/>
<person name="Muroyama R."/>
<person name="Taniguchi H."/>
<person name="Guleng B."/>
<person name="Dharel N."/>
<person name="Shao R.X."/>
<person name="Tateishi K."/>
<person name="Jazag A."/>
<person name="Kawabe T."/>
<person name="Omata M."/>
</authorList>
<dbReference type="PubMed" id="19840259"/>
<dbReference type="DOI" id="10.1111/j.1478-3231.2009.02144.x"/>
</citation>
<scope>FUNCTION IN HCV RESTRICTION</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2010" name="Mol. Biol. Cell" volume="21" first="3449" last="3458">
<title>The double-stranded RNA-dependent protein kinase differentially regulates insulin receptor substrates 1 and 2 in HepG2 cells.</title>
<authorList>
<person name="Yang X."/>
<person name="Nath A."/>
<person name="Opperman M.J."/>
<person name="Chan C."/>
</authorList>
<dbReference type="PubMed" id="20685959"/>
<dbReference type="DOI" id="10.1091/mbc.E10-06-0481"/>
</citation>
<scope>FUNCTION</scope>
<scope>PHOSPHORYLATION AT THR-451</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2010" name="Sci. Signal." volume="3" first="RA3" last="RA3">
<title>Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Vermeulen M."/>
<person name="Santamaria A."/>
<person name="Kumar C."/>
<person name="Miller M.L."/>
<person name="Jensen L.J."/>
<person name="Gnad F."/>
<person name="Cox J."/>
<person name="Jensen T.S."/>
<person name="Nigg E.A."/>
<person name="Brunak S."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="20068231"/>
<dbReference type="DOI" id="10.1126/scisignal.2000475"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-83</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="47">
<citation type="journal article" date="2011" name="BMC Syst. Biol." volume="5" first="17" last="17">
<title>Initial characterization of the human central proteome.</title>
<authorList>
<person name="Burkard T.R."/>
<person name="Planyavsky M."/>
<person name="Kaupe I."/>
<person name="Breitwieser F.P."/>
<person name="Buerckstuemmer T."/>
<person name="Bennett K.L."/>
<person name="Superti-Furga G."/>
<person name="Colinge J."/>
</authorList>
<dbReference type="PubMed" id="21269460"/>
<dbReference type="DOI" id="10.1186/1752-0509-5-17"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="48">
<citation type="journal article" date="2011" name="Brain Pathol." volume="21" first="189" last="200">
<title>Modulation of tau phosphorylation by the kinase PKR: implications in Alzheimer's disease.</title>
<authorList>
<person name="Bose A."/>
<person name="Mouton-Liger F."/>
<person name="Paquet C."/>
<person name="Mazot P."/>
<person name="Vigny M."/>
<person name="Gray F."/>
<person name="Hugon J."/>
</authorList>
<dbReference type="PubMed" id="21029237"/>
<dbReference type="DOI" id="10.1111/j.1750-3639.2010.00437.x"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2011" name="Curr. Opin. Immunol." volume="23" first="573" last="582">
<title>Protein kinase PKR and RNA adenosine deaminase ADAR1: new roles for old players as modulators of the interferon response.</title>
<authorList>
<person name="Pfaller C.K."/>
<person name="Li Z."/>
<person name="George C.X."/>
<person name="Samuel C.E."/>
</authorList>
<dbReference type="PubMed" id="21924887"/>
<dbReference type="DOI" id="10.1016/j.coi.2011.08.009"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2011" name="J. Interferon Cytokine Res." volume="31" first="59" last="70">
<title>The role of protein kinase R in the interferon response.</title>
<authorList>
<person name="Pindel A."/>
<person name="Sadler A."/>
</authorList>
<dbReference type="PubMed" id="21166592"/>
<dbReference type="DOI" id="10.1089/jir.2010.0099"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2011" name="Leukemia" volume="25" first="236" last="245">
<title>Multiple forms of PKR present in the nuclei of acute leukemia cells represent an active kinase that is responsive to stress.</title>
<authorList>
<person name="Blalock W.L."/>
<person name="Bavelloni A."/>
<person name="Piazzi M."/>
<person name="Tagliavini F."/>
<person name="Faenza I."/>
<person name="Martelli A.M."/>
<person name="Follo M.Y."/>
<person name="Cocco L."/>
</authorList>
<dbReference type="PubMed" id="21072047"/>
<dbReference type="DOI" id="10.1038/leu.2010.264"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY</scope>
<scope>PHOSPHORYLATION</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2011" name="Mol. Cells" volume="32" first="167" last="172">
<title>PKR-dependent mechanisms of interferon-? for inhibiting hepatitis B virus replication.</title>
<authorList>
<person name="Park I.H."/>
<person name="Baek K.W."/>
<person name="Cho E.Y."/>
<person name="Ahn B.Y."/>
</authorList>
<dbReference type="PubMed" id="21710204"/>
<dbReference type="DOI" id="10.1007/s10059-011-1059-6"/>
</citation>
<scope>FUNCTION IN HBV RESTRICTION</scope>
</reference>
<reference key="53">
<citation type="journal article" date="2012" name="Cell Cycle" volume="11" first="407" last="417">
<title>The RAX/PACT-PKR stress response pathway promotes p53 sumoylation and activation, leading to G(1) arrest.</title>
<authorList>
<person name="Bennett R.L."/>
<person name="Pan Y."/>
<person name="Christian J."/>
<person name="Hui T."/>
<person name="May W.S. Jr."/>
</authorList>
<dbReference type="PubMed" id="22214662"/>
<dbReference type="DOI" id="10.4161/cc.11.2.18999"/>
</citation>
<scope>FUNCTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2012" name="Immunity" volume="36" first="695" last="696">
<title>Penetration resistance: PKR's other talent.</title>
<authorList>
<person name="Lacy-Hulbert A."/>
<person name="Stuart L.M."/>
</authorList>
<dbReference type="PubMed" id="22633454"/>
<dbReference type="DOI" id="10.1016/j.immuni.2012.05.010"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2012" name="J. Biol. Chem." volume="287" first="36384" last="36392">
<title>Protein kinase PKR amplification of interferon beta induction occurs through initiation factor eIF-2alpha-mediated translational control.</title>
<authorList>
<person name="McAllister C.S."/>
<person name="Taghavi N."/>
<person name="Samuel C.E."/>
</authorList>
<dbReference type="PubMed" id="22948139"/>
<dbReference type="DOI" id="10.1074/jbc.M112.390039"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2012" name="Mol. Cell" volume="48" first="667" last="680">
<title>Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity.</title>
<authorList>
<person name="Shen S."/>
<person name="Niso-Santano M."/>
<person name="Adjemian S."/>
<person name="Takehara T."/>
<person name="Malik S.A."/>
<person name="Minoux H."/>
<person name="Souquere S."/>
<person name="Marino G."/>
<person name="Lachkar S."/>
<person name="Senovilla L."/>
<person name="Galluzzi L."/>
<person name="Kepp O."/>
<person name="Pierron G."/>
<person name="Maiuri M.C."/>
<person name="Hikita H."/>
<person name="Kroemer R."/>
<person name="Kroemer G."/>
</authorList>
<dbReference type="PubMed" id="23084476"/>
<dbReference type="DOI" id="10.1016/j.molcel.2012.09.013"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH STAT3</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2012" name="Mol. Cell. Proteomics" volume="11" first="M111.015131" last="M111.015131">
<title>Comparative large-scale characterisation of plant vs. mammal proteins reveals similar and idiosyncratic N-alpha acetylation features.</title>
<authorList>
<person name="Bienvenut W.V."/>
<person name="Sumpton D."/>
<person name="Martinez A."/>
<person name="Lilla S."/>
<person name="Espagne C."/>
<person name="Meinnel T."/>
<person name="Giglione C."/>
</authorList>
<dbReference type="PubMed" id="22223895"/>
<dbReference type="DOI" id="10.1074/mcp.M111.015131"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="58">
<citation type="journal article" date="2012" name="Nature" volume="488" first="670" last="674">
<title>Novel role of PKR in inflammasome activation and HMGB1 release.</title>
<authorList>
<person name="Lu B."/>
<person name="Nakamura T."/>
<person name="Inouye K."/>
<person name="Li J."/>
<person name="Tang Y."/>
<person name="Lundbaeck P."/>
<person name="Valdes-Ferrer S.I."/>
<person name="Olofsson P.S."/>
<person name="Kalb T."/>
<person name="Roth J."/>
<person name="Zou Y."/>
<person name="Erlandsson-Harris H."/>
<person name="Yang H."/>
<person name="Ting J.P."/>
<person name="Wang H."/>
<person name="Andersson U."/>
<person name="Antoine D.J."/>
<person name="Chavan S.S."/>
<person name="Hotamisligil G.S."/>
<person name="Tracey K.J."/>
</authorList>
<dbReference type="PubMed" id="22801494"/>
<dbReference type="DOI" id="10.1038/nature11290"/>
</citation>
<scope>FUNCTION</scope>
<scope>INTERACTION WITH NLRP1; NLRP3; NLRC4 AND AIM2</scope>
<scope>AUTOPHOSPHORYLATION</scope>
</reference>
<reference key="59">
<citation type="journal article" date="2012" name="Proc. Natl. Acad. Sci. U.S.A." volume="109" first="12449" last="12454">
<title>N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB.</title>
<authorList>
<person name="Van Damme P."/>
<person name="Lasa M."/>
<person name="Polevoda B."/>
<person name="Gazquez C."/>
<person name="Elosegui-Artola A."/>
<person name="Kim D.S."/>
<person name="De Juan-Pardo E."/>
<person name="Demeyer K."/>
<person name="Hole K."/>
<person name="Larrea E."/>
<person name="Timmerman E."/>
<person name="Prieto J."/>
<person name="Arnesen T."/>
<person name="Sherman F."/>
<person name="Gevaert K."/>
<person name="Aldabe R."/>
</authorList>
<dbReference type="PubMed" id="22814378"/>
<dbReference type="DOI" id="10.1073/pnas.1210303109"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="60">
<citation type="journal article" date="2012" name="Sci. Signal." volume="5" first="PE47" last="PE47">
<title>PKR-dependent inflammatory signals.</title>
<authorList>
<person name="Kang R."/>
<person name="Tang D."/>
</authorList>
<dbReference type="PubMed" id="23092889"/>
<dbReference type="DOI" id="10.1126/scisignal.2003511"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="61">
<citation type="journal article" date="2012" name="Virology" volume="427" first="208" last="216">
<title>Protein kinase PKR catalytic activity is required for the PKR-dependent activation of mitogen-activated protein kinases and amplification of interferon beta induction following virus infection.</title>
<authorList>
<person name="Taghavi N."/>
<person name="Samuel C.E."/>
</authorList>
<dbReference type="PubMed" id="22381929"/>
<dbReference type="DOI" id="10.1016/j.virol.2012.01.029"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="62">
<citation type="journal article" date="2012" name="Viruses" volume="4" first="2598" last="2635">
<title>dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection.</title>
<authorList>
<person name="Dabo S."/>
<person name="Meurs E.F."/>
</authorList>
<dbReference type="PubMed" id="23202496"/>
<dbReference type="DOI" id="10.3390/v4112598"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="63">
<citation type="journal article" date="2013" name="Blood" volume="121" first="3364" last="3374">
<title>PKR regulates proliferation, differentiation and survival of murine hematopoietic stem/progenitor cells.</title>
<authorList>
<person name="Liu X."/>
<person name="Bennett R.L."/>
<person name="Cheng X."/>
<person name="Byrne M."/>
<person name="Reinhard M.K."/>
<person name="May W.S. Jr."/>
</authorList>
<dbReference type="PubMed" id="23403623"/>
<dbReference type="DOI" id="10.1182/blood-2012-09-456400"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="64">
<citation type="journal article" date="2013" name="Cell. Mol. Life Sci." volume="70" first="3493" last="3511">
<title>The eIF2alpha kinases: their structures and functions.</title>
<authorList>
<person name="Donnelly N."/>
<person name="Gorman A.M."/>
<person name="Gupta S."/>
<person name="Samali A."/>
</authorList>
<dbReference type="PubMed" id="23354059"/>
<dbReference type="DOI" id="10.1007/s00018-012-1252-6"/>
</citation>
<scope>REVIEW</scope>
</reference>
<reference key="65">
<citation type="journal article" date="2013" name="J. Biol. Chem." volume="288" first="2839" last="2847">
<title>Activation of double-stranded RNA-activated protein kinase (PKR) by interferon-stimulated gene 15 (ISG15) modification down-regulates protein translation.</title>
<authorList>
<person name="Okumura F."/>
<person name="Okumura A.J."/>
<person name="Uematsu K."/>
<person name="Hatakeyama S."/>
<person name="Zhang D.E."/>
<person name="Kamura T."/>
</authorList>
<dbReference type="PubMed" id="23229543"/>
<dbReference type="DOI" id="10.1074/jbc.M112.401851"/>
</citation>
<scope>FUNCTION</scope>
<scope>ISGYLATION AT LYS-69 AND LYS-159</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="66">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-542</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="67">
<citation type="journal article" date="2013" name="J. Virol." volume="87" first="3710" last="3718">
<title>Toscana virus NSs protein promoftes degradation of double-stranded RNA-dependent protein kinase.</title>
<authorList>
<person name="Kalveram B."/>
<person name="Ikegami T."/>
</authorList>
<dbReference type="PubMed" id="23325696"/>
<dbReference type="DOI" id="10.1128/JVI.02506-12"/>
</citation>
<scope>INTERACTION WITH TOSCANA VIRUS PROTEIN NSS</scope>
<scope>ENZYME REGULATION</scope>
</reference>
<reference key="68">
<citation type="journal article" date="2013" name="J. Virol." volume="87" first="756" last="766">
<title>Stress granule formation induced by measles virus is protein kinase PKR dependent and impaired by RNA adenosine deaminase ADAR1.</title>
<authorList>
<person name="Okonski K.M."/>
<person name="Samuel C.E."/>
</authorList>
<dbReference type="PubMed" id="23115276"/>
<dbReference type="DOI" id="10.1128/JVI.02270-12"/>
</citation>
<scope>FUNCTION IN MV RESTRICTION</scope>
</reference>
<reference key="69">
<citation type="journal article" date="2013" name="PLoS ONE" volume="8" first="E55108" last="E55108">
<title>Protein kinase regulated by dsRNA downregulates the interferon production in dengue virus- and dsrna-stimulated human lung epithelial cells.</title>
<authorList>
<person name="Li Y."/>
<person name="Xie J."/>
<person name="Wu S."/>
<person name="Xia J."/>
<person name="Zhang P."/>
<person name="Liu C."/>
<person name="Zhang P."/>
<person name="Huang X."/>
</authorList>
<dbReference type="PubMed" id="23372823"/>
<dbReference type="DOI" id="10.1371/journal.pone.0055108"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="70">
<citation type="journal article" date="2013" name="Virology" volume="438" first="28" last="36">
<title>The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells.</title>
<authorList>
<person name="Zhang L."/>
<person name="Alter H.J."/>
<person name="Wang H."/>
<person name="Jia S."/>
<person name="Wang E."/>
<person name="Marincola F.M."/>
<person name="Shih J.W."/>
<person name="Wang R.Y."/>
</authorList>
<dbReference type="PubMed" id="23399035"/>
<dbReference type="DOI" id="10.1016/j.virol.2013.01.015"/>
</citation>
<scope>FUNCTION IN HCV RESTRICTION</scope>
</reference>
<reference key="71">
<citation type="journal article" date="2015" name="J. Virol." volume="89" first="5382" last="5394">
<title>Mutational analysis of vaccinia virus E3 protein: the biological functions do not correlate with its biochemical capacity to bind double-stranded RNA.</title>
<authorList>
<person name="Dueck K.J."/>
<person name="Hu Y.S."/>
<person name="Chen P."/>
<person name="Deschambault Y."/>
<person name="Lee J."/>
<person name="Varga J."/>
<person name="Cao J."/>
</authorList>
<dbReference type="PubMed" id="25740987"/>
<dbReference type="DOI" id="10.1128/JVI.03288-14"/>
</citation>
<scope>INTERACTION WITH VACCINIA VIRUS PROTEIN E3</scope>
</reference>
<reference key="72">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="73">
<citation type="journal article" date="1998" name="EMBO J." volume="17" first="5458" last="5465">
<title>Structure of the double-stranded RNA-binding domain of the protein kinase PKR reveals the molecular basis of its dsRNA-mediated activation.</title>
<authorList>
<person name="Nanduri S."/>
<person name="Carpick B.W."/>
<person name="Yang Y."/>
<person name="Williams B.R.G."/>
<person name="Qin J."/>
</authorList>
<dbReference type="PubMed" id="9736623"/>
<dbReference type="DOI" id="10.1093/emboj/17.18.5458"/>
</citation>
<scope>STRUCTURE BY NMR OF 1-175</scope>
</reference>
<reference key="74">
<citation type="journal article" date="2005" name="Cell" volume="122" first="887" last="900">
<title>Higher-order substrate recognition of eIF2alpha by the RNA-dependent protein kinase PKR.</title>
<authorList>
<person name="Dar A.C."/>
<person name="Dever T.E."/>
<person name="Sicheri F."/>
</authorList>
<dbReference type="PubMed" id="16179258"/>
<dbReference type="DOI" id="10.1016/j.cell.2005.06.044"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 258-550 IN COMPLEX WITH EIF2ALPHA</scope>
<scope>PHOSPHORYLATION AT THR-446</scope>
</reference>
<reference key="75">
<citation type="journal article" date="2007" name="Nature" volume="446" first="153" last="158">
<title>Patterns of somatic mutation in human cancer genomes.</title>
<authorList>
<person name="Greenman C."/>
<person name="Stephens P."/>
<person name="Smith R."/>
<person name="Dalgliesh G.L."/>
<person name="Hunter C."/>
<person name="Bignell G."/>
<person name="Davies H."/>
<person name="Teague J."/>
<person name="Butler A."/>
<person name="Stevens C."/>
<person name="Edkins S."/>
<person name="O'Meara S."/>
<person name="Vastrik I."/>
<person name="Schmidt E.E."/>
<person name="Avis T."/>
<person name="Barthorpe S."/>
<person name="Bhamra G."/>
<person name="Buck G."/>
<person name="Choudhury B."/>
<person name="Clements J."/>
<person name="Cole J."/>
<person name="Dicks E."/>
<person name="Forbes S."/>
<person name="Gray K."/>
<person name="Halliday K."/>
<person name="Harrison R."/>
<person name="Hills K."/>
<person name="Hinton J."/>
<person name="Jenkinson A."/>
<person name="Jones D."/>
<person name="Menzies A."/>
<person name="Mironenko T."/>
<person name="Perry J."/>
<person name="Raine K."/>
<person name="Richardson D."/>
<person name="Shepherd R."/>
<person name="Small A."/>
<person name="Tofts C."/>
<person name="Varian J."/>
<person name="Webb T."/>
<person name="West S."/>
<person name="Widaa S."/>
<person name="Yates A."/>
<person name="Cahill D.P."/>
<person name="Louis D.N."/>
<person name="Goldstraw P."/>
<person name="Nicholson A.G."/>
<person name="Brasseur F."/>
<person name="Looijenga L."/>
<person name="Weber B.L."/>
<person name="Chiew Y.-E."/>
<person name="DeFazio A."/>
<person name="Greaves M.F."/>
<person name="Green A.R."/>
<person name="Campbell P."/>
<person name="Birney E."/>
<person name="Easton D.F."/>
<person name="Chenevix-Trench G."/>
<person name="Tan M.-H."/>
<person name="Khoo S.K."/>
<person name="Teh B.T."/>
<person name="Yuen S.T."/>
<person name="Leung S.Y."/>
<person name="Wooster R."/>
<person name="Futreal P.A."/>
<person name="Stratton M.R."/>
</authorList>
<dbReference type="PubMed" id="17344846"/>
<dbReference type="DOI" id="10.1038/nature05610"/>
</citation>
<scope>VARIANTS [LARGE SCALE ANALYSIS] GLU-428; VAL-439 AND VAL-506</scope>
</reference>
<comment type="function">
<text evidence="16 21 23 24 32 33 34 35 36 37 38 39 41 42 43 44 45 46 47 48 49 50 52 53">IFN-induced dsRNA-dependent serine/threonine-protein kinase which plays a key role in the innate immune response to viral infection and is also involved in the regulation of signal transduction, apoptosis, cell proliferation and differentiation. Exerts its antiviral activity on a wide range of DNA and RNA viruses including hepatitis C virus (HCV), hepatitis B virus (HBV), measles virus (MV) and herpes simplex virus 1 (HHV-1). Inhibits viral replication via phosphorylation of the alpha subunit of eukaryotic initiation factor 2 (EIF2S1), this phosphorylation impairs the recycling of EIF2S1 between successive rounds of initiation leading to inhibition of translation which eventually results in shutdown of cellular and viral protein synthesis. Also phosphorylates other substrates including p53/TP53, PPP2R5A, DHX9, ILF3, IRS1 and the HHV-1 viral protein US11. In addition to serine/threonine-protein kinase activity, also has tyrosine-protein kinase activity and phosphorylates CDK1 at 'Tyr-4' upon DNA damage, facilitating its ubiquitination and proteosomal degradation. Either as an adapter protein and/or via its kinase activity, can regulate various signaling pathways (p38 MAP kinase, NF-kappa-B and insulin signaling pathways) and transcription factors (JUN, STAT1, STAT3, IRF1, ATF3) involved in the expression of genes encoding proinflammatory cytokines and IFNs. Activates the NF-kappa-B pathway via interaction with IKBKB and TRAF family of proteins and activates the p38 MAP kinase pathway via interaction with MAP2K6. Can act as both a positive and negative regulator of the insulin signaling pathway (ISP). Negatively regulates ISP by inducing the inhibitory phosphorylation of insulin receptor substrate 1 (IRS1) at 'Ser-312' and positively regulates ISP via phosphorylation of PPP2R5A which activates FOXO1, which in turn up-regulates the expression of insulin receptor substrate 2 (IRS2). Can regulate NLRP3 inflammasome assembly and the activation of NLRP3, NLRP1, AIM2 and NLRC4 inflammasomes. Can trigger apoptosis via FADD-mediated activation of CASP8. Plays a role in the regulation of the cytoskeleton by binding to gelsolin (GSN), sequestering the protein in an inactive conformation away from actin.</text>
</comment>
<comment type="catalytic activity">
<text>ATP + a protein = ADP + a phosphoprotein.</text>
</comment>
<comment type="catalytic activity">
<text evidence="14">ATP + a [protein]-L-tyrosine = ADP + a [protein]-L-tyrosine phosphate.</text>
</comment>
<comment type="enzyme regulation">
<text evidence="22 31 32 50 51">Initially produced in an inactive form and is activated by binding to viral dsRNA, which causes dimerization and autophosphorylation in the activation loop and stimulation of function. ISGylation can activate it in the absence of viral infection. Can also be activated by heparin, proinflammatory stimuli, growth factors, cytokines, oxidative stress and the cellular protein PRKRA. Activity is markedly stimulated by manganese ions. Activation is blocked by the viral components HIV-1 Tat protein and large amounts of HIV-1 trans-activation response (TAR) RNA element as well as by the cellular proteins TARBP2, DUS2L, NPM1, NCK1 and ADAR. Down-regulated by Toscana virus (TOS) and Rift valley fever virus (RVFV) NSS which promote its proteasomal degradation. Inhibited by vaccinia virus protein E3, probably via dsRNA sequestering.</text>
</comment>
<comment type="subunit">
<text evidence="11 15 16 20 22 23 24 25 26 29 31 32 34 46 48 55 56 57 58 59">Homodimer. Interacts with STRBP (By similarity). Interacts with DNAJC3. Forms a complex with FANCA, FANCC, FANCG and HSP70. Interacts with ADAR/ADAR1. Interacts with IRS1 (By similarity). The inactive form interacts with NCK1 and GSN. Interacts (via the kinase catalytic domain) with STAT3 (via SH2 domain), TRAF2 (C-terminus), TRAF5 (C-terminus) and TRAF6 (C-terminus). Interacts with MAP2K6, IKBKB/IKKB, NPM1, TARBP2, NLRP1, NLRP3, NLRC4 and AIM2. Interacts (via DRBM 1 domain) with DUS2L (via DRBM domain). Interacts with DHX9 (via N-terminus) and this interaction is dependent upon activation of the kinase.</text>
</comment>
<comment type="subunit">
<text evidence="18 21 51 55">(Microbial infection) Interacts with human herpes simplex virus 1 (HHV-1) protein US11 in an RNA-dependent manner (PubMed:11836380). The inactive form interacts with Toscana virus (TOS) NSS (PubMed:23325696). Interacts with herpes virus 8 protein v-IRF2; this interaction inhibits EIF2AK2 activation (PubMed:11160738). Interacts with vaccinia protein E3 (PubMed:25740987).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-6918883">
<id>O92972</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-6904269">
<id>P27958</id>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-444308">
<id>P06493</id>
<label>CDK1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-1211456">
<id>Q7L2E3</id>
<label>DHX30</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-744193">
<id>Q96C10</id>
<label>DHX58</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-352022">
<id>Q08211</id>
<label>DHX9</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-395506">
<id>Q9UPY3</id>
<label>DICER1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-640793">
<id>Q27968</id>
<label>DNAJC3</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>5</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-1006038">
<id>Q6P2E9</id>
<label>EDC4</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-1056162">
<id>P05198</id>
<label>EIF2S1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-372243">
<id>P56537</id>
<label>EIF6</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-744088">
<id>Q8IY81</id>
<label>FTSJ3</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-8674942">
<id>P20639</id>
<label>K3L</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-1055820">
<id>Q9HCE1</id>
<label>MOV10</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-78579">
<id>P06748</id>
<label>NPM1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-713955">
<id>O75569</id>
<label>PRKRA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-722938">
<id>Q9NUL3</id>
<label>STAU2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-978581">
<id>Q15633</id>
<label>TARBP2</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-74615">
<id>Q9H0E2</id>
<label>TOLLIP</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-6150681">
<id>P04487</id>
<label>US11</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-8876177">
<id>Q2HR71</id>
<label>vIRF-2</label>
</interactant>
<organismsDiffer>true</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-640775"/>
<interactant intactId="EBI-2462313">
<id>Q9UL40</id>
<label>ZNF346</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Perinuclear region</location>
</subcellularLocation>
<text>Nuclear localization is elevated in acute leukemia, myelodysplastic syndrome (MDS), melanoma, breast, colon, prostate and lung cancer patient samples or cell lines as well as neurocytes from advanced Creutzfeldt-Jakob disease patients.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>P19525-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>P19525-2</id>
<name>2</name>
<sequence type="described" ref="VSP_046177"/>
<text>No experimental confirmation available.</text>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="40 54">Highly expressed in thymus, spleen and bone marrow compared to non-hematopoietic tissues such as small intestine, liver, or kidney tissues. Colocalizes with GSK3B and TAU in the Alzheimer disease (AD) brain. Elevated levels seen in breast and colon carcinomas,and which correlates with tumor progression and invasiveness or risk of progression.</text>
</comment>
<comment type="induction">
<text evidence="28">By type I interferons.</text>
</comment>
<comment type="PTM">
<text evidence="17 19 26 27 39 40 41">Autophosphorylated on several Ser, Thr and Tyr residues. Autophosphorylation of Thr-451 is dependent on Thr-446 and is stimulated by dsRNA binding and dimerization. Autophosphorylation apparently leads to the activation of the kinase. Tyrosine autophosphorylation is essential for efficient dsRNA-binding, dimerization, and kinase activation.</text>
</comment>
<comment type="similarity">
<text evidence="12">Belongs to the protein kinase superfamily. Ser/Thr protein kinase family. GCN2 subfamily.</text>
</comment>
<comment type="online information" name="NIEHS-SNPs">
<link uri="http://egp.gs.washington.edu/data/prkr/"/>
</comment>
<comment type="online information" name="Atlas of Genetics and Cytogenetics in Oncology and Haematology">
<link uri="http://atlasgeneticsoncology.org/Genes/EIF2AK2ID41866ch2p22.html"/>
</comment>
<dbReference type="EC" id="2.7.11.1"/>
<dbReference type="EC" id="2.7.10.2"/>
<dbReference type="EMBL" id="M35663">
<property type="protein sequence ID" value="AAA36409.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="M85294">
<property type="protein sequence ID" value="AAA18253.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="U50648">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50634">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50635">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50636">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50637">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50638">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50639">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50640">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50641">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50642">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50643">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50644">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50645">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50646">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="U50647">
<property type="protein sequence ID" value="AAC50768.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167472">
<property type="protein sequence ID" value="AAF13156.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167460">
<property type="protein sequence ID" value="AAF13156.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167462">
<property type="protein sequence ID" value="AAF13156.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167463">
<property type="protein sequence ID" value="AAF13156.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167464">
<property type="protein sequence ID" value="AAF13156.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167465">
<property type="protein sequence ID" value="AAF13156.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167466">
<property type="protein sequence ID" value="AAF13156.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167468">
<property type="protein sequence ID" value="AAF13156.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AF167470">
<property type="protein sequence ID" value="AAF13156.1"/>
<property type="status" value="JOINED"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY302136">
<property type="protein sequence ID" value="AAP57628.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290655">
<property type="protein sequence ID" value="BAF83344.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK313818">
<property type="protein sequence ID" value="BAG36554.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY228338">
<property type="protein sequence ID" value="AAO38055.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AC007899">
<property type="protein sequence ID" value="AAY24317.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471053">
<property type="protein sequence ID" value="EAX00407.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471053">
<property type="protein sequence ID" value="EAX00408.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471053">
<property type="protein sequence ID" value="EAX00409.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC093676">
<property type="protein sequence ID" value="AAH93676.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC101475">
<property type="protein sequence ID" value="AAI01476.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS1786.1">
<molecule id="P19525-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46259.1">
<molecule id="P19525-2"/>
</dbReference>
<dbReference type="PIR" id="JC5225">
<property type="entry name" value="JC5225"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001129123.1">
<molecule id="P19525-1"/>
<property type="nucleotide sequence ID" value="NM_001135651.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001129124.1">
<molecule id="P19525-2"/>
<property type="nucleotide sequence ID" value="NM_001135652.2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_002750.1">
<molecule id="P19525-1"/>
<property type="nucleotide sequence ID" value="NM_002759.3"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011531289.1">
<molecule id="P19525-1"/>
<property type="nucleotide sequence ID" value="XM_011532987.2"/>
</dbReference>
<dbReference type="UniGene" id="Hs.131431"/>
<dbReference type="PDB" id="1QU6">
<property type="method" value="NMR"/>
<property type="chains" value="A=1-170"/>
</dbReference>
<dbReference type="PDB" id="2A19">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.50"/>
<property type="chains" value="B/C=258-538"/>
</dbReference>
<dbReference type="PDB" id="2A1A">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.80"/>
<property type="chains" value="B=258-538"/>
</dbReference>
<dbReference type="PDB" id="3UIU">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.90"/>
<property type="chains" value="A/B=254-551"/>
</dbReference>
<dbReference type="PDBsum" id="1QU6"/>
<dbReference type="PDBsum" id="2A19"/>
<dbReference type="PDBsum" id="2A1A"/>
<dbReference type="PDBsum" id="3UIU"/>
<dbReference type="ProteinModelPortal" id="P19525"/>
<dbReference type="SMR" id="P19525"/>
<dbReference type="BioGrid" id="111596">
<property type="interactions" value="99"/>
</dbReference>
<dbReference type="DIP" id="DIP-2657N"/>
<dbReference type="IntAct" id="P19525">
<property type="interactions" value="62"/>
</dbReference>
<dbReference type="MINT" id="MINT-92415"/>
<dbReference type="STRING" id="9606.ENSP00000233057"/>
<dbReference type="BindingDB" id="P19525"/>
<dbReference type="ChEMBL" id="CHEMBL5785"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2016"/>
<dbReference type="iPTMnet" id="P19525"/>
<dbReference type="PhosphoSitePlus" id="P19525"/>
<dbReference type="SwissPalm" id="P19525"/>
<dbReference type="BioMuta" id="EIF2AK2"/>
<dbReference type="DMDM" id="125527"/>
<dbReference type="EPD" id="P19525"/>
<dbReference type="MaxQB" id="P19525"/>
<dbReference type="PaxDb" id="P19525"/>
<dbReference type="PeptideAtlas" id="P19525"/>
<dbReference type="PRIDE" id="P19525"/>
<dbReference type="TopDownProteomics" id="P19525-1">
<molecule id="P19525-1"/>
</dbReference>
<dbReference type="DNASU" id="5610"/>
<dbReference type="Ensembl" id="ENST00000233057">
<molecule id="P19525-1"/>
<property type="protein sequence ID" value="ENSP00000233057"/>
<property type="gene ID" value="ENSG00000055332"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000395127">
<molecule id="P19525-1"/>
<property type="protein sequence ID" value="ENSP00000378559"/>
<property type="gene ID" value="ENSG00000055332"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000405334">
<molecule id="P19525-2"/>
<property type="protein sequence ID" value="ENSP00000385014"/>
<property type="gene ID" value="ENSG00000055332"/>
</dbReference>
<dbReference type="GeneID" id="5610"/>
<dbReference type="KEGG" id="hsa:5610"/>
<dbReference type="UCSC" id="uc010fab.3">
<molecule id="P19525-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="5610"/>
<dbReference type="DisGeNET" id="5610"/>
<dbReference type="GeneCards" id="EIF2AK2"/>
<dbReference type="HGNC" id="HGNC:9437">
<property type="gene designation" value="EIF2AK2"/>
</dbReference>
<dbReference type="HPA" id="CAB003845"/>
<dbReference type="HPA" id="HPA019795"/>
<dbReference type="HPA" id="HPA063893"/>
<dbReference type="MIM" id="176871">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_P19525"/>
<dbReference type="OpenTargets" id="ENSG00000055332"/>
<dbReference type="PharmGKB" id="PA33779"/>
<dbReference type="eggNOG" id="KOG1033">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410XS0B">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00530000062984"/>
<dbReference type="HOGENOM" id="HOG000234351"/>
<dbReference type="HOVERGEN" id="HBG051430"/>
<dbReference type="InParanoid" id="P19525"/>
<dbReference type="KO" id="K16195"/>
<dbReference type="OMA" id="ELLYICP"/>
<dbReference type="OrthoDB" id="EOG091G088F"/>
<dbReference type="PhylomeDB" id="P19525"/>
<dbReference type="TreeFam" id="TF317576"/>
<dbReference type="Reactome" id="R-HSA-1169408">
<property type="pathway name" value="ISG15 antiviral mechanism"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-169131">
<property type="pathway name" value="Inhibition of PKR"/>
</dbReference>
<dbReference type="SignaLink" id="P19525"/>
<dbReference type="SIGNOR" id="P19525"/>
<dbReference type="ChiTaRS" id="EIF2AK2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="P19525"/>
<dbReference type="GeneWiki" id="Protein_kinase_R"/>
<dbReference type="GenomeRNAi" id="5610"/>
<dbReference type="PMAP-CutDB" id="P19525"/>
<dbReference type="PRO" id="PR:P19525"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 2"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000055332"/>
<dbReference type="CleanEx" id="HS_EIF2AK2"/>
<dbReference type="ExpressionAtlas" id="P19525">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="P19525">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0016020">
<property type="term" value="C:membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005840">
<property type="term" value="C:ribosome"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="AgBase"/>
</dbReference>
<dbReference type="GO" id="GO:0005524">
<property type="term" value="F:ATP binding"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0003725">
<property type="term" value="F:double-stranded RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="MGI"/>
</dbReference>
<dbReference type="GO" id="GO:0004694">
<property type="term" value="F:eukaryotic translation initiation factor 2alpha kinase activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004715">
<property type="term" value="F:non-membrane spanning protein tyrosine kinase activity"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-EC"/>
</dbReference>
<dbReference type="GO" id="GO:0004672">
<property type="term" value="F:protein kinase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019888">
<property type="term" value="F:protein phosphatase regulator activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0004674">
<property type="term" value="F:protein serine/threonine kinase activity"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0003723">
<property type="term" value="F:RNA binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000186">
<property type="term" value="P:activation of MAPKK activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034198">
<property type="term" value="P:cellular response to amino acid starvation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051607">
<property type="term" value="P:defense response to virus"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0030968">
<property type="term" value="P:endoplasmic reticulum unfolded protein response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0030683">
<property type="term" value="P:evasion or tolerance by virus of host immune response"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0043066">
<property type="term" value="P:negative regulation of apoptotic process"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell proliferation"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="ProtInc"/>
</dbReference>
<dbReference type="GO" id="GO:0033689">
<property type="term" value="P:negative regulation of osteoblast proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017148">
<property type="term" value="P:negative regulation of translation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045071">
<property type="term" value="P:negative regulation of viral genome replication"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032722">
<property type="term" value="P:positive regulation of chemokine production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0001819">
<property type="term" value="P:positive regulation of cytokine production"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051092">
<property type="term" value="P:positive regulation of NF-kappaB transcription factor activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901224">
<property type="term" value="P:positive regulation of NIK/NF-kappaB signaling"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032874">
<property type="term" value="P:positive regulation of stress-activated MAPK cascade"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046777">
<property type="term" value="P:protein autophosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006468">
<property type="term" value="P:protein phosphorylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1901532">
<property type="term" value="P:regulation of hematopoietic progenitor cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902036">
<property type="term" value="P:regulation of hematopoietic stem cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1902033">
<property type="term" value="P:regulation of hematopoietic stem cell proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900225">
<property type="term" value="P:regulation of NLRP3 inflammasome complex assembly"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035455">
<property type="term" value="P:response to interferon-alpha"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0009636">
<property type="term" value="P:response to toxic substance"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="InterPro"/>
</dbReference>
<dbReference type="GO" id="GO:0009615">
<property type="term" value="P:response to virus"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006351">
<property type="term" value="P:transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0006412">
<property type="term" value="P:translation"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR014720">
<property type="entry name" value="dsRBD_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR011009">
<property type="entry name" value="Kinase-like_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR033366">
<property type="entry name" value="PKR"/>
</dbReference>
<dbReference type="InterPro" id="IPR000719">
<property type="entry name" value="Prot_kinase_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR017441">
<property type="entry name" value="Protein_kinase_ATP_BS"/>
</dbReference>
<dbReference type="InterPro" id="IPR008271">
<property type="entry name" value="Ser/Thr_kinase_AS"/>
</dbReference>
<dbReference type="PANTHER" id="PTHR11042:SF107">
<property type="entry name" value="PTHR11042:SF107"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="Pfam" id="PF00035">
<property type="entry name" value="dsrm"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="Pfam" id="PF00069">
<property type="entry name" value="Pkinase"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SMART" id="SM00358">
<property type="entry name" value="DSRM"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="SMART" id="SM00220">
<property type="entry name" value="S_TKc"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF56112">
<property type="entry name" value="SSF56112"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50137">
<property type="entry name" value="DS_RBD"/>
<property type="match status" value="2"/>
</dbReference>
<dbReference type="PROSITE" id="PS00107">
<property type="entry name" value="PROTEIN_KINASE_ATP"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50011">
<property type="entry name" value="PROTEIN_KINASE_DOM"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS00108">
<property type="entry name" value="PROTEIN_KINASE_ST"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0051">Antiviral defense</keyword>
<keyword id="KW-0067">ATP-binding</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0903">Direct protein sequencing</keyword>
<keyword id="KW-0945">Host-virus interaction</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-1017">Isopeptide bond</keyword>
<keyword id="KW-0418">Kinase</keyword>
<keyword id="KW-0547">Nucleotide-binding</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0677">Repeat</keyword>
<keyword id="KW-0694">RNA-binding</keyword>
<keyword id="KW-0723">Serine/threonine-protein kinase</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0829">Tyrosine-protein kinase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<feature type="initiator methionine" description="Removed" evidence="8 9 60">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="Interferon-induced, double-stranded RNA-activated protein kinase" id="PRO_0000085945">
<location>
<begin position="2"/>
<end position="551"/>
</location>
</feature>
<feature type="domain" description="DRBM 1" evidence="13">
<location>
<begin position="9"/>
<end position="77"/>
</location>
</feature>
<feature type="domain" description="DRBM 2" evidence="13">
<location>
<begin position="100"/>
<end position="167"/>
</location>
</feature>
<feature type="domain" description="Protein kinase" evidence="12">
<location>
<begin position="267"/>
<end position="538"/>
</location>
</feature>
<feature type="repeat" description="1">
<location>
<begin position="331"/>
<end position="343"/>
</location>
</feature>
<feature type="repeat" description="2">
<location>
<begin position="345"/>
<end position="357"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="ATP" evidence="12">
<location>
<begin position="273"/>
<end position="281"/>
</location>
</feature>
<feature type="region of interest" description="Interaction with TRAF5" evidence="23">
<location>
<begin position="266"/>
<end position="551"/>
</location>
</feature>
<feature type="region of interest" description="2 X 13 AA approximate repeats">
<location>
<begin position="331"/>
<end position="357"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="12 14">
<location>
<position position="414"/>
</location>
</feature>
<feature type="binding site" description="ATP">
<location>
<position position="296"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="8 9 60">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5 6 7 17">
<location>
<position position="83"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="64">
<location>
<position position="88"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="64">
<location>
<position position="89"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="64">
<location>
<position position="90"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="27">
<location>
<position position="101"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="27">
<location>
<position position="162"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by autocatalysis" evidence="64">
<location>
<position position="242"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="64">
<location>
<position position="255"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="64">
<location>
<position position="258"/>
</location>
</feature>
<feature type="modified residue" description="Phosphotyrosine; by autocatalysis" evidence="27">
<location>
<position position="293"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="19 26">
<location>
<position position="446"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by autocatalysis" evidence="19 39">
<location>
<position position="451"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="5">
<location>
<position position="456"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="10">
<location>
<position position="542"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15)" evidence="50">
<location>
<position position="69"/>
</location>
</feature>
<feature type="cross-link" description="Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ISG15)" evidence="50">
<location>
<position position="159"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_046177" evidence="62">
<location>
<begin position="263"/>
<end position="303"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs56219559." id="VAR_040474" evidence="30">
<original>V</original>
<variation>E</variation>
<location>
<position position="428"/>
</location>
</feature>
<feature type="sequence variant" description="In a lung adenocarcinoma sample; somatic mutation." id="VAR_040475" evidence="30">
<original>L</original>
<variation>V</variation>
<location>
<position position="439"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34821155." id="VAR_040476" evidence="30">
<original>I</original>
<variation>V</variation>
<location>
<position position="506"/>
</location>
</feature>
<feature type="mutagenesis site" description="In FL-PKR-2AI; moderate loss of activity but no effect on dsRNA binding." evidence="19">
<original>SK</original>
<variation>AA</variation>
<location>
<begin position="59"/>
<end position="60"/>
</location>
</feature>
<feature type="mutagenesis site" description="Impairs dsRNA binding but not dimerization or activity." evidence="19">
<original>K</original>
<variation>A</variation>
<location>
<position position="60"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significant loss of activity; loss of dsRNA binding and dimerization." evidence="19">
<original>A</original>
<variation>E</variation>
<location>
<position position="67"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on enzymatic activity; when associated with A-88; A-89 and A-90." evidence="17">
<original>S</original>
<variation>A</variation>
<location>
<position position="83"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on enzymatic activity; when associated with A-83; A-89 and A-90." evidence="17">
<original>T</original>
<variation>A</variation>
<location>
<position position="88"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on enzymatic activity; when associated with A-83; A-88 and A-90." evidence="17">
<original>T</original>
<variation>A</variation>
<location>
<position position="89"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on enzymatic activity; when associated with A-83; A-88 and A-89." evidence="17">
<original>T</original>
<variation>A</variation>
<location>
<position position="90"/>
</location>
</feature>
<feature type="mutagenesis site" description="In FL-PKR-2AII; no effect on activity." evidence="19">
<original>TK</original>
<variation>AA</variation>
<location>
<begin position="149"/>
<end position="150"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderate loss of activity; when associated with A-255 and A-258." evidence="17">
<original>S</original>
<variation>A</variation>
<location>
<position position="242"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="19">
<location>
<begin position="244"/>
<end position="296"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderate loss of activity; when associated with A-242 and A-255." evidence="17">
<original>T</original>
<variation>A</variation>
<location>
<position position="255"/>
</location>
</feature>
<feature type="mutagenesis site" description="Moderate loss of activity." evidence="17">
<original>T</original>
<variation>A</variation>
<location>
<position position="258"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="17">
<original>K</original>
<variation>R</variation>
<location>
<position position="296"/>
</location>
</feature>
<feature type="mutagenesis site" description="Significant loss of activity and impairs autophosphorylation of T-451." evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="446"/>
</location>
</feature>
<feature type="mutagenesis site" description="Loss of activity." evidence="19">
<original>T</original>
<variation>A</variation>
<location>
<position position="451"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAP57628." ref="7" evidence="63">
<original>I</original>
<variation>M</variation>
<location>
<position position="102"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 7; AAP57628." ref="7" evidence="63">
<original>S</original>
<variation>R</variation>
<location>
<position position="224"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6; AAF13156." ref="6" evidence="63">
<original>K</original>
<variation>E</variation>
<location>
<position position="512"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="5"/>
<end position="7"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="10"/>
<end position="21"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="26"/>
<end position="32"/>
</location>
</feature>
<feature type="turn" evidence="1">
<location>
<begin position="35"/>
<end position="37"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="41"/>
<end position="50"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="54"/>
<end position="56"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="61"/>
<end position="76"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="102"/>
<end position="111"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="115"/>
<end position="123"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="125"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="144"/>
<end position="149"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="150"/>
<end position="167"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="261"/>
<end position="266"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="267"/>
<end position="274"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="276"/>
<end position="278"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="281"/>
<end position="286"/>
</location>
</feature>
<feature type="turn" evidence="2">
<location>
<begin position="287"/>
<end position="289"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="292"/>
<end position="299"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="303"/>
<end position="305"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="306"/>
<end position="314"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="323"/>
<end position="332"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="358"/>
<end position="366"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="374"/>
<end position="380"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="381"/>
<end position="383"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="388"/>
<end position="407"/>
</location>
</feature>
<feature type="strand" evidence="3">
<location>
<begin position="410"/>
<end position="412"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="417"/>
<end position="419"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="420"/>
<end position="424"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="427"/>
<end position="430"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="437"/>
<end position="440"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="457"/>
<end position="461"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="468"/>
<end position="482"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="488"/>
<end position="499"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="505"/>
<end position="507"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="509"/>
<end position="518"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="523"/>
<end position="525"/>
</location>
</feature>
<feature type="helix" evidence="2">
<location>
<begin position="529"/>
<end position="538"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="1QU6"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2A19"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="2A1A"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3UIU"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="18669648"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19690332"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="20068231"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22223895"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="22814378"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000250"/>
<evidence key="12" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00159"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00266"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU10027"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10390359"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10848580"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11152499"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11160738"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11337501"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11438532"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11836380"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12882984"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15121867"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15229216"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15299030"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16179258"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16373505"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="1695551"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17079286"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17344846"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18096616"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18835251"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19189853"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19229320"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19507191"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19840259"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20171114"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20395957"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20685959"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21029237"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21072047"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21123651"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21710204"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22214662"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22381929"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22801494"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22948139"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23084476"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23115276"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23229543"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23325696"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23372823"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23399035"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23403623"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25740987"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="8576172"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9079663"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9143277"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="9781815"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000269">
<source ref="13"/>
</evidence>
<evidence key="61" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="11438532"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000303">
<source ref="7"/>
</evidence>
<evidence key="63" type="ECO:0000305"/>
<evidence key="64" type="ECO:0000305">
<source>
<dbReference type="PubMed" id="11152499"/>
</source>
</evidence>
<sequence length="551" mass="62094" checksum="815AD83ACAB45DA3" modified="1991-05-01" version="2">
MAGDLSAGFFMEELNTYRQKQGVVLKYQELPNSGPPHDRRFTFQVIIDGREFPEGEGRSK
KEAKNAAAKLAVEILNKEKKAVSPLLLTTTNSSEGLSMGNYIGLINRIAQKKRLTVNYEQ
CASGVHGPEGFHYKCKMGQKEYSIGTGSTKQEAKQLAAKLAYLQILSEETSVKSDYLSSG
SFATTCESQSNSLVTSTLASESSSEGDFSADTSEINSNSDSLNSSSLLMNGLRNNQRKAK
RSLAPRFDLPDMKETKYTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKY
NNEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTK
CLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNI
FLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE
LLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK
KSPEKNERHTC
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>